The phase I study of concurrent chemoradiotherapy using a combination of gemcitabine and nab-paclitaxel for unresectable locally advanced pancreatic cancer: Update.

被引：0
|
作者：
Ioka, Tatsuya
Katayama, Kazuhiro
Takada, Ryoji
Ohkawa, Kazuyoshi
Takahashi, Hidenori
Teshima, Teruki
机构：
[1] Osaka Med Ctr Canc & Cardiovasc Dis, Hepatobiliary & Pancreat Oncol, Osaka, Japan
[2] Osaka Med Ctr Canc & CVD, Dept Pancreat Surg, Osaka, Japan
[3] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.462
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
462
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer
    Suguru Yamada
    Tsutomu Fujii
    Yukihiro Yokoyama
    Hiroki Kawashima
    Osamu Maeda
    Kojiro Suzuki
    Tohru Okada
    Eizaburo Ono
    Junpei Yamaguchi
    Nao Takano
    Hideki Takami
    Masamichi Hayashi
    Yukiko Niwa
    Yoshiki Hirooka
    Yoshiyuki Ito
    Shinji Naganawa
    Yuichi Ando
    Masato Nagino
    Hidemi Goto
    Yasuhiro Kodera
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 815 - 821
  • [2] Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer
    Yamada, Suguru
    Fujii, Tsutomu
    Yokoyama, Yukihiro
    Kawashima, Hiroki
    Maeda, Osamu
    Suzuki, Kojiro
    Okada, Tohru
    Ono, Eizaburo
    Yamaguchi, Junpei
    Takano, Nao
    Takami, Hideki
    Hayashi, Masamichi
    Niwa, Yukiko
    Hirooka, Yoshiki
    Ito, Yoshiyuki
    Naganawa, Shinji
    Ando, Yuichi
    Nagino, Masato
    Goto, Hidemi
    Kodera, Yasuhiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (05) : 815 - 821
  • [3] Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer.
    Yamada, Suguru
    Fujii, Tsutomu
    Takano, Nao
    Takami, Hideki
    Suenaga, Masaya
    Niwa, Yukiko
    Hayashi, Masamichi
    Iwata, Naoki
    Kanda, Mitsuro
    Kobayashi, Daisuke
    Tanaka, Chie
    Nakayama, Goro
    Sugimoto, Hiroyuki
    Koike, Masahiko
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [4] Phase I study of nab-paclitaxel and gemcitabine combination in patients with advanced pancreatic cancer
    Drengler, R. L.
    Smith, L. S.
    Wood, T. E.
    Borad, M. J.
    Ramanathan, R. K.
    Laheru, D. A.
    Hidalgo, M.
    Von Hoff, D. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] EFFICACY OF GEMCITABINE/NAB-PACLITAXEL INDUCTION CHEMOTHERAPY FOLLOWED BY CHEMORADIOTHERAPY FOR UNRESECTABLE LOCALLY ADVANCED PANCREATIC CANCER
    Takada, Ryoji
    Ikezawa, Kenji
    Kiyota, Ryosuke
    Imai, Toshihiro
    Yutaro, Abe
    Fukutake, Nobuyasu
    Takatoshi, Nawa
    Katayama, Kazuhiro
    Ohkawa, Kazuyoshi
    GASTROENTEROLOGY, 2020, 158 (06) : S865 - S866
  • [6] The Phase 1 Study of Concurrent Chemoradiation Therapy With Gemcitabine and Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Adenocarcinoma Patients
    Ioka, T.
    Katayama, K.
    Takada, R.
    Fukutake, N.
    Ohkawa, K.
    Akita, H.
    Takahashi, H.
    Konishi, K.
    Teshima, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S205 - S205
  • [7] Phase I Study of Chemoradiation Therapy (nab-Paclitaxel/Gemcitabine) in 18 Patients with Unresectable Locally Advanced Pancreatic Adenocarcinoma
    Ioka, Tatsuya
    Katayama, Kazuhiro
    Hibino, Kenji
    Yutaro, Abe
    Tamura, Takeshi
    Takada, Ryoji
    Fukutake, Nobuyasu
    Ashida, Reiko
    Ohkawa, Kazuyoshi
    Akita, Hiroshi
    Takahashi, Hidenori
    Hirata, Takero
    Teshima, Teruki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 147 - 147
  • [8] The Survival Benefit of Chemoradiotherapy following Induction Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Cancer
    Takada, Ryoji
    Ikezawa, Kenji
    Daiku, Kazuma
    Maeda, Shingo
    Abe, Yutaro
    Urabe, Makiko
    Kai, Yugo
    Yamai, Takuo
    Fukutake, Nobuyasu
    Nakabori, Tasuku
    Uehara, Hiroyuki
    Ashida, Reiko
    Akita, Hirofumi
    Takahashi, Hidenori
    Teshima, Teruki
    Ohkawa, Kazuyoshi
    CANCERS, 2021, 13 (18)
  • [9] Phase I trial of enzalutamide in combination with gemcitabine and nab-paclitaxel in the management of advanced pancreatic cancer
    Kommalapati, A.
    Kim, R.
    Harsha, T. Sri
    Bertels, B.
    Wapinsky, G.
    Burke, N.
    Neuger, A.
    Springett, G.
    Almhanna, K.
    Mahipal, A.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E135 - E135
  • [10] Phase I study of chemoradiation therapy (nab-paclitaxel/Gemcitabine) in 15 patients with unresectable locally advanced pancreatic cancer (UR-LAPC).
    Sueyoshi, Hironari
    Ioka, Tatsuya
    Tamura, Takeshi
    Takada, Ryoji
    Fukutake, Nobuyasu
    Ashida, Reiko
    Ohkawa, Kazuyoshi
    Takahashi, Hidenori
    Teshima, Teruki
    Katayama, Kazuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
12345